Journal of Microbiology, Immunology, and Infection This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
CONCLUSION: We found a high rate of respiratory failure and mortality among patients with HM who contracted the SARS-CoV-2. Factors associated with developing respiratory failure or mortality in 60 days included receipt of allo-HSCT, type 2 diabetes mellitus and lymphopenia upon admission. Having received ≥2 doses of vaccination conferred protection against clinical progression.PMID:38480093 | DOI:10.1016/j.jmii.2024.03.001 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 13, 2024 Category: Microbiology Authors: Tzong-Yow Wu Wan-Ting Tsai Kai-Hsiang Chen Szu-Ting Huang Chun-Fu Huang Po-Hsien Kuo Ming-Jui Tsai Wang-Da Liu Kuan-Yin Lin Yu-Shan Huang Aristine Cheng Pao-Yu Chen Hsin-Yun Sun Huai-Hsuan Huang Tai-Chung Huang Shang-Ju Wu Ming Yao Jann-Tay Wang Wang-Huei Source Type: research
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
CONCLUSION: We found a high rate of respiratory failure and mortality among patients with HM who contracted the SARS-CoV-2. Factors associated with developing respiratory failure or mortality in 60 days included receipt of allo-HSCT, type 2 diabetes mellitus and lymphopenia upon admission. Having received ≥2 doses of vaccination conferred protection against clinical progression.PMID:38480093 | DOI:10.1016/j.jmii.2024.03.001 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 13, 2024 Category: Microbiology Authors: Tzong-Yow Wu Wan-Ting Tsai Kai-Hsiang Chen Szu-Ting Huang Chun-Fu Huang Po-Hsien Kuo Ming-Jui Tsai Wang-Da Liu Kuan-Yin Lin Yu-Shan Huang Aristine Cheng Pao-Yu Chen Hsin-Yun Sun Huai-Hsuan Huang Tai-Chung Huang Shang-Ju Wu Ming Yao Jann-Tay Wang Wang-Huei Source Type: research
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
CONCLUSION: We found a high rate of respiratory failure and mortality among patients with HM who contracted the SARS-CoV-2. Factors associated with developing respiratory failure or mortality in 60 days included receipt of allo-HSCT, type 2 diabetes mellitus and lymphopenia upon admission. Having received ≥2 doses of vaccination conferred protection against clinical progression.PMID:38480093 | DOI:10.1016/j.jmii.2024.03.001 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 13, 2024 Category: Microbiology Authors: Tzong-Yow Wu Wan-Ting Tsai Kai-Hsiang Chen Szu-Ting Huang Chun-Fu Huang Po-Hsien Kuo Ming-Jui Tsai Wang-Da Liu Kuan-Yin Lin Yu-Shan Huang Aristine Cheng Pao-Yu Chen Hsin-Yun Sun Huai-Hsuan Huang Tai-Chung Huang Shang-Ju Wu Ming Yao Jann-Tay Wang Wang-Huei Source Type: research
Application of a multiplex molecular pneumonia panel and real-world impact on antimicrobial stewardship among patients with hospital-acquired and ventilator-associated pneumonia in intensive care units
CONCLUSIONS: This study identified several factors predicting bacterial detection by FAPP in critically ill patients with HAP/VAP. More than 50% real-world clinical practices were adjusted or confirmed based on the FAPP results. Clinical algorithms for the use of FAPP and antimicrobial stewardship guidelines may further enhance its benefits.PMID:38471985 | DOI:10.1016/j.jmii.2024.02.010 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 12, 2024 Category: Microbiology Authors: Chieh-Lung Chen How-Yang Tseng Wei-Cheng Chen Shinn-Jye Liang Chih-Yen Tu Yu-Chao Lin Po-Ren Hsueh Source Type: research
The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan
CONCLUSIONS: Esomeprazole-based HDDT achieved over 90% eradication rates but rabeprazole-based HDDT, which failed.PMID:38461114 | DOI:10.1016/j.jmii.2024.02.009 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 9, 2024 Category: Microbiology Authors: Wei-Chen Tai I-Ting Wu Hsin-Ming Wang Pao-Yuan Huang Chih-Chien Yao Cheng-Kun Wu Shih-Cheng Yang Chih-Ming Liang Pin-I Hsu Seng-Kee Chuah Source Type: research
The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan
CONCLUSIONS: Esomeprazole-based HDDT achieved over 90% eradication rates but rabeprazole-based HDDT, which failed.PMID:38461114 | DOI:10.1016/j.jmii.2024.02.009 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 9, 2024 Category: Microbiology Authors: Wei-Chen Tai I-Ting Wu Hsin-Ming Wang Pao-Yuan Huang Chih-Chien Yao Cheng-Kun Wu Shih-Cheng Yang Chih-Ming Liang Pin-I Hsu Seng-Kee Chuah Source Type: research
The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan
CONCLUSIONS: Esomeprazole-based HDDT achieved over 90% eradication rates but rabeprazole-based HDDT, which failed.PMID:38461114 | DOI:10.1016/j.jmii.2024.02.009 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 9, 2024 Category: Microbiology Authors: Wei-Chen Tai I-Ting Wu Hsin-Ming Wang Pao-Yuan Huang Chih-Chien Yao Cheng-Kun Wu Shih-Cheng Yang Chih-Ming Liang Pin-I Hsu Seng-Kee Chuah Source Type: research
The multicenter real-world report of the efficacies of 14-day esomeprazole-based and rabeprazole-based high-dose dual therapy in first-line Helicobacter pylori eradication in Taiwan
CONCLUSIONS: Esomeprazole-based HDDT achieved over 90% eradication rates but rabeprazole-based HDDT, which failed.PMID:38461114 | DOI:10.1016/j.jmii.2024.02.009 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 9, 2024 Category: Microbiology Authors: Wei-Chen Tai I-Ting Wu Hsin-Ming Wang Pao-Yuan Huang Chih-Chien Yao Cheng-Kun Wu Shih-Cheng Yang Chih-Ming Liang Pin-I Hsu Seng-Kee Chuah Source Type: research
Copper affects virulence and diverse phenotypes of uropathogenic Proteus mirabilis
CONCLUSION: The finding of copper-mediated virulence and fitness reinforced the importance of copper for prevention and therapeutic interventions against P. mirabilis infections. As such, this study could facilitate the copper-based strategies against UTI by P. mirabilis.PMID:38453541 | DOI:10.1016/j.jmii.2024.02.007 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 7, 2024 Category: Microbiology Authors: Wei-Syuan Huang Yuan-Ju Lee Lu Wang Hsuan-Hsuan Chen Yueh-Jung Chao Vivien Cheng Shwu-Jen Liaw Source Type: research
Copper affects virulence and diverse phenotypes of uropathogenic Proteus mirabilis
CONCLUSION: The finding of copper-mediated virulence and fitness reinforced the importance of copper for prevention and therapeutic interventions against P. mirabilis infections. As such, this study could facilitate the copper-based strategies against UTI by P. mirabilis.PMID:38453541 | DOI:10.1016/j.jmii.2024.02.007 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 7, 2024 Category: Microbiology Authors: Wei-Syuan Huang Yuan-Ju Lee Lu Wang Hsuan-Hsuan Chen Yueh-Jung Chao Vivien Cheng Shwu-Jen Liaw Source Type: research
Combination of trimethoprim-sulfamethoxazole and clindamycin in the treatment of relapsing toxoplasmic encephalitis
J Microbiol Immunol Infect. 2024 Feb 28:S1684-1182(24)00045-8. doi: 10.1016/j.jmii.2024.02.008. Online ahead of print.NO ABSTRACTPMID:38443217 | DOI:10.1016/j.jmii.2024.02.008 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 5, 2024 Category: Microbiology Authors: Shih-Wen Ting Jien-Wei Liu Source Type: research
Combination of trimethoprim-sulfamethoxazole and clindamycin in the treatment of relapsing toxoplasmic encephalitis
J Microbiol Immunol Infect. 2024 Feb 28:S1684-1182(24)00045-8. doi: 10.1016/j.jmii.2024.02.008. Online ahead of print.NO ABSTRACTPMID:38443217 | DOI:10.1016/j.jmii.2024.02.008 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 5, 2024 Category: Microbiology Authors: Shih-Wen Ting Jien-Wei Liu Source Type: research
Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV
CONCLUSIONS: PWH receiving different types of the third dose of COVID-19 vaccine showed similar vaccine effectiveness against SARS-CoV-2 infection. An additional dose with 100-μg mRNA-1273 could generate a higher antibody response than with 50-μg mRNA-1273 and BNT162b2 vaccine.PMID:38429206 | DOI:10.1016/j.jmii.2024.02.004 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 1, 2024 Category: Microbiology Authors: Wang-Da Liu Meng-Shuan Lin Hsin-Yun Sun Ming-Chieh Shih Yu-Chung Chuang Yu-Shan Huang Kuan-Yin Lin Guei-Chi Li Pei-Ying Wu Ling-Ya Chen Wen-Chun Liu Yi-Ching Su Pu-Chi He Yi-Ting Chen Chia-Yi Lin Yu-Chen Cheng Yi Yao Yi-Chen Yeh Chia-Chi Liu Mei-Yan Pan Y Source Type: research
Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV
CONCLUSIONS: PWH receiving different types of the third dose of COVID-19 vaccine showed similar vaccine effectiveness against SARS-CoV-2 infection. An additional dose with 100-μg mRNA-1273 could generate a higher antibody response than with 50-μg mRNA-1273 and BNT162b2 vaccine.PMID:38429206 | DOI:10.1016/j.jmii.2024.02.004 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 1, 2024 Category: Microbiology Authors: Wang-Da Liu Meng-Shuan Lin Hsin-Yun Sun Ming-Chieh Shih Yu-Chung Chuang Yu-Shan Huang Kuan-Yin Lin Guei-Chi Li Pei-Ying Wu Ling-Ya Chen Wen-Chun Liu Yi-Ching Su Pu-Chi He Yi-Ting Chen Chia-Yi Lin Yu-Chen Cheng Yi Yao Yi-Chen Yeh Chia-Chi Liu Mei-Yan Pan Y Source Type: research
Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV
CONCLUSIONS: PWH receiving different types of the third dose of COVID-19 vaccine showed similar vaccine effectiveness against SARS-CoV-2 infection. An additional dose with 100-μg mRNA-1273 could generate a higher antibody response than with 50-μg mRNA-1273 and BNT162b2 vaccine.PMID:38429206 | DOI:10.1016/j.jmii.2024.02.004 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - March 1, 2024 Category: Microbiology Authors: Wang-Da Liu Meng-Shuan Lin Hsin-Yun Sun Ming-Chieh Shih Yu-Chung Chuang Yu-Shan Huang Kuan-Yin Lin Guei-Chi Li Pei-Ying Wu Ling-Ya Chen Wen-Chun Liu Yi-Ching Su Pu-Chi He Yi-Ting Chen Chia-Yi Lin Yu-Chen Cheng Yi Yao Yi-Chen Yeh Chia-Chi Liu Mei-Yan Pan Y Source Type: research